Preventing surgical site infections: A randomized, open-label trial of nasal mupirocin ointment and nasal povidone-iodine solution

Infection Control and Hospital Epidemiology

Volumn 35, Issue 7, 2014, Pages 826-832

  Phillips, Michael ^a,b   Rosenberg, Andrew ^a,b   Shopsin, Bo ^a,b   Cuff, Germaine ^b   Skeete, Faith ^a   Foti, Alycia ^a   Kraemer, Kandy ^a   Inglima, Kenneth ^a   Press, Robert ^a,b   Bosco, Joseph ^a,b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTROBAN NASAL; CEFAZOLIN; CHLORHEXIDINE; CLINDAMYCIN; POVIDONE IODINE; PSEUDOMONIC ACID; UNCLASSIFIED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT; OINTMENT;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTHROPLASTY; ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; FAINTNESS; FEMALE; HEADACHE; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NOSE OBSTRUCTION; OINTMENT; OPEN STUDY; PATHOGEN CLEARANCE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RHINORRHEA; SKIN DISEASE; SKIN TEST; SORE THROAT; SPINE FUSION; SURGICAL INFECTION; ANTIBIOTIC PROPHYLAXIS; COMPARATIVE STUDY; DRUG EFFECTS; INTRANASAL DRUG ADMINISTRATION; MICROBIOLOGY; MIDDLE AGED; NOSE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURGICAL WOUND INFECTION; VERY ELDERLY; YOUNG ADULT;

ADMINISTRATION, INTRANASAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ARTHROPLASTY; FEMALE; HUMANS; INTENTION TO TREAT ANALYSIS; MALE; MIDDLE AGED; MUPIROCIN; NOSE; OINTMENTS; POVIDONE-IODINE; SPINAL FUSION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURGICAL WOUND INFECTION; YOUNG ADULT;

EID: 84902985079     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/676872     Document Type: Article

References (25)

1. Klevens RM, Edwards JR, Richards CL, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007;122(2):160-166
2. Renaud A, Lavigne M, Vendittoli PA. Periprosthetic joint infections at a teaching hospital in 1990-2007. Can J Surg 2012;55(6): 394-400
3. Kurtz SM, Lau E, Ong KL, et al. Infection risk for primary and revision instrumented lumbar spine fusion in the Medicare population. J Neurosurg Spine 2012;17(4):342-347
4. Kurtz SM, Lau E, Watson H, et al. Economic burden of periprosthetic joint infection in the United States. J Arthroplasty 2012;27(8 suppl):61-65, e1
5. Bode LG, Kluytmans JA, Wertheim HF, et al. Preventing surgicalsite infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010;362(1):9-17
6. Ramos N, Skeete F, Haas JP, et al. Surgical site infection prevention initiative: patient attitude and compliance. Bull NYU Hosp Jt Dis 2011;69(4):312-315
7. Cookson B, Farrelly H, Palepou MF, et al. Mupirocin-resistant Staphylococcus aureus. Lancet 1992;339(8793):625
8. Annigeri R, Conly J, Vas S, et al. Emergence of mupirocinresistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit Dial Int 2001;21(6):554-559
9. McNeil JC, Hulton KG, Kaplan SL, Mason EQ. Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children. Antimicrob Agents Chemother 2011; 55(5):2431-2433
10. Bathoorn E, Hetem DJ, Alphenaar J, Kusters JG, Bonten MJ. Emergence of high-level mupirocin resistance in coagulase-negative staphylococci associated with increased short-term mupirocin use. J Clin Microbiol 2012;50(9):2947-2950
11. Layton MC, Perez M, Heald P, Patterson JE. An outbreak of mupirocin-resistant Staphylococcus aureus on a dermatology ward associated with an environmental reservoir. Infect Control Hosp Epidemiol 1993;14(7):369-375
12. Jayakumar S, Meerabai M, Shameem Banu AS, Renu M, Kalyani M, Binesh Lal Y. Prevalence of high and low level mupirocin resistance among staphylococcal isolates from skin infection in a tertiary care hospital. J Clin Diagn Res 2013;7(2):238-242
13. Hill RL, Casewell MW. The in-vitro activity of povidoneiodinecream against Staphylococcus aureus and its bioavailability in nasal secretions. J Hosp Infect 2000;45(3):198-205
14. Shopsin B, Gomez M, Montgomery SO, et al. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol 1999;37(11): 3556-3563
15. Hallin M, Deplano A, Denis O, De Mendonça R, De Ryck R, Struelens MJ. Validation of pulsed-field gel electrophoresis and spa typing for long-term, nationwide epidemiological surveillance studies of Staphylococcus aureus infections. J ClinMicrobiol 2007;45(1):127-133
16. Hallin M, Friedrich AW, Struelens MJ. spa typing for epidemiological surveillance of Staphylococcus aureus. Methods Mol Biol 2009;551:189-202
17. Eltringham I. Mupirocin resistance and methicillin-resistant Staphylococcus aureus (MRSA). J Hosp Infect 1997;35(1):1-8
18. Slover J, Haas JP, Quirno M, Phillips MS, Bosco JA 3rd. Costeffectiveness of a Staphylococcus aureus screening and decolonization program for high-risk orthopedic patients. J Arthroplasty 2011;26(3):360-365
19. VandenBergh MF, Kluytmans JA, van Hout BA, et al. Costeffectiveness of perioperative mupirocin nasal ointment in cardiothoracic surgery. Infect Control Hosp Epidemiol 1996;17(12): 786-792
20. Young LS, Winston LG. Preoperative use of mupirocin for the prevention of healthcare-associated Staphylococcus aureus infections: a cost-effectiveness analysis. Infect Control Hosp Epidemiol 2006;27(12):1304-1312
21. Courville XF, Tomek IM, Kirkland KB, Birhle M, Kantor SR, Finlayson SR. Cost-effectiveness of preoperative nasal mupirocin treatment in preventing surgical site infection in patients undergoing total hip and knee arthroplasty: a cost-effectiveness analysis. Infect Control Hosp Epidemiol 2012;33(2):152-159
22. Porter ME. What is value in health care? N Engl J Med 2010; 363(26):2477-2481
23. Enquist M, Bosco JA 3rd, Pazand L, Habibi KA, Donoghue RJ, Zuckerman JD. Managing episodes of care: strategies for orthopaedic surgeons in the era of reform. J Bone Joint Surg Am 2011;93(10):e55
24. Matheson A, Christie P, Stari T, Kavanagh K, Gould IM, Masterton R, Reilly JS. Nasal swab screening for methicillin-resistant Staphylococcus aureus: how well does it perform? a cross-sectional study. Infect Control Hosp Epidemiol 2012;33(8):803-808
25. Senn L, Basset P, Nahimana I, Zanetti G, Blanc DS. Which anatomical sites should be sampled for screening of methicillinresistant Staphylococcus aureus carriage by culture or by rapid PCR test? Clin Microbiol Infect 2012;18(2):E31-E3.